Nature Publishing Group

SHERPA: Yellow

People

  1. Reuter
    Reuter
  2. Ladanyi
    Ladanyi
  3. Al-Ahmadie
    Al-Ahmadie
  4. Fine
    Fine
  5. Gopalan
    Gopalan
  6. Tickoo
    Tickoo
  7. Antonescu
    Antonescu
  8. Shia
    Shia
  9. Chen
    Chen
  10. Weigelt
    Weigelt

Groups

  1. GSK Faculty (2498)
  2. Department of Medicine (2046)
  3. Department of Pathology and Laboratory Medicine (1930)
  4. Sloan Kettering Institute Faculty (1422)
  5. Sloan Kettering Institute Postdocs (1260)
  6. Center for Hematologic Malignancies (1096)
  7. Hematologic Malignancies, Division of (1002)
  8. Solid Tumor Oncology Division (990)
  9. Center for Molecular Imaging and Biotechnology (CMIB) (963)
  10. Tow Center for Developmental Oncology (TCDO) (891)
Search Within
Formats
  1. Journal Article (3661)
  2. Meeting Abstract (2162)
  3. Review (191)
  4. Editorial (101)
  5. Research Letter (96)
  6. Correspondence (32)
  7. Conference Paper (23)
  8. Guidelines (13)
  9. Miscellaneous (9)
Groups
  1. GSK Faculty (2498)
  2. Department of Medicine (2046)
  3. Department of Pathology and Laboratory Medicine (1930)
  4. Sloan Kettering Institute Faculty (1422)
  5. Sloan Kettering Institute Postdocs (1260)
  6. Center for Hematologic Malignancies (1096)

More Groups

People
  1. Victor Reuter (297)
  2. Marc Ladanyi (225)
  3. Hikmat Al-Ahmadie (197)
  4. David Klimstra (195)
  5. Robert Soslow (165)
  6. Samson Fine (159)

More People

Years
  1. 2025 (327)
  2. 2024 (365)
  3. 2023 (326)
  4. 2022 (356)
  5. 2021 (316)
  6. 2020 (375)

More Years

Publications
  1. Laboratory Investigation (1890)
  2. Nature (604)
  3. Nature Communications (453)
  4. Bone Marrow Transplantation (381)
  5. Leukemia (283)
  6. Nature Medicine (249)

More Publications

Results (6288)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The simplified comorbidity index stratifies non-relapse mortality in patients receiving allogeneic hematopoietic stem cell transplant after reduced-intensity conditioning: A CIBMTR validation study
    Meeting Abstract

    Shouval, R.; Brown, S.; Devlin, S. M.; Elias, S.; Allbee-Johnson, M.; Pasquini, M.; Chhabra, S.; Perales, M. A.
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Outcomes in patients with B-cell precursor acute lymphoblastic leukemia who received inotuzumab ozogamicin and proceeded to hematopoietic stem cell transplantation: A registry-based, observational study
    Meeting Abstract

    Marks, D.; de Lima, M.; Kebriaei, P.; Lanza, F.; Cho, C.; Popradi, G.; Zhang, M. J.; Zhang, F.; Welch, V.; Tikka, S.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Early lymphocyte immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplantation for malignant indications: A tri-institutional analysis
    Meeting Abstract

    Lucas, A. T.; Lindemans, C.; Bhoopalan, S. V.; Dandis, R.; Prockop, S.; Naik, S.; Keerthi, D.; de Koning, C.; Sharma, A.; Nierkens, S.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • A randomized phase 3 study of allogeneic HCT with Iomab-B versus conventional care in older patients with active, relapsed/refractory AML: Pivotal SIERRA trial results
    Meeting Abstract

    Giralt, S.; Gyurkocza, B.; Seropian, S.; Choe, H.; Litzow, M.; Abboud, C.; Koshy, N.; Stiff, P.; Tomlinson, B.; Abhyankar, S.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • A prospective study of allogeneic stem cell transplantation of A/B T-lymphocyte depleted graft conditioned with a reduced intensity regimen in patients with hematologic malignancies
    Meeting Abstract

    Tamari, R.; Flynn, J.; Shaffer, B.; Jakubowski, A.; Papadopoulos, E.; Devlin, S.; Lin, R.; Giralt, S.; Perales, M. A.
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • An open-label, single-arm study of letermovir (LTV) for prevention of recurrent CMV infection in highrisk allogeneic hematopoietic cell transplant (HCT) recipients
    Meeting Abstract

    Han, G.; Su, Y.; Stern, A.; Shaffer, B.; Perales, M. A.; Young, J. A.; Papanicolaou, G. A.
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Multinational study assessing treatment patterns, outcomes, and healthcare resource utilization in hematopoietic stem cell transplant recipients with refractory/resistant cytomegalovirus infection, or intolerance to anti-cytomegalovirus therapies
    Meeting Abstract

    Papanicolaou, G.; Peggs, K.; Sanz, J.; Fox, M. L.; Einsele, H.; Avery, R.; Mendonça, I.; Veloso, L.; Sundberg, A.; Bo, T.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Idecabtagene vicleucel versus standard regimens in patients with triple-class–exposed relapsed and refractory multiple myeloma: KarMMa-3, a phase 3 randomized controlled trial
    Meeting Abstract

    Rodríguez-Otero, P.; Ailawadhi, S.; Arnulf, B.; Patel, K.; Cavo, M.; Nooka, A. K.; Manier, S.; Callander, N.; Costa, L. J.; Vij, R.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • A reproducible inflammatory biomarker signature identifies non-Hodgkin lymphoma patients at high risk of CAR-T treatment failure across different cohorts
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fei, T.; Fein, J.; Tomas, A. A.; De LaPuerta, M. C.; Dahi, P.; Danylesko, I.; Epstein-Peterson, Z.; Fried, S.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Protecting public health in Iran in the face of oppression
    Correspondence

    Patel, T.; Hammond, A.; Nasari, A.; Sani, K.; Dee, E. C.; Jain, B.; Sabeti, P. C.
    Nature Medicine (2023)

    Fulltext@MSK | Save